Literature DB >> 28375517

Life After USA300: The Rise and Fall of a Superbug.

Paul J Planet1,2,3.   

Abstract

The community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) epidemic in the United States is largely attributable to the meteoric rise of a single clone, referred to as USA300. This strain not only spread across the United States in just a few years to become the predominant cause of staphylococcal disease, but it also appears to have increased the overall number of skin and soft-tissue infections (SSTIs), increasing the overall disease burden. While USA300 still constitutes a major public health burden, its prevalence may be decreasing in some parts of the United States. Other than an epidemic in South America due to a closely related strain, USA300 also seems to have been largely unable to establish itself as an endemic infection in other geographic locations. While there have been several hypotheses put forward to explain the enormous success of USA300, the reasons for its failures and its potential fall remain obscure. Far from being unique to USA300, the rise and fall of specific clones of S. aureus in human populations seems to be a common process that has occurred multiple times and in multiple locations. This review charts the rise of USA300 and the evidence that suggests that it may be in decline, and it considers how best to understand the future spread, containment, and possible extinction of CA-MRSA.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  MRSA; Staphylococcus aureus; USA300; epidemic; phylogenomics

Mesh:

Substances:

Year:  2017        PMID: 28375517      PMCID: PMC5853207          DOI: 10.1093/infdis/jiw444

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  114 in total

1.  Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails.

Authors:  Erica S Pan; Binh A Diep; Heather A Carleton; Edwin D Charlebois; George F Sensabaugh; Barbara L Haller; Françoise Perdreau-Remington
Journal:  Clin Infect Dis       Date:  2003-10-17       Impact factor: 9.079

2.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

3.  Health care-associated invasive MRSA infections, 2005-2008.

Authors:  Alexander J Kallen; Yi Mu; Sandra Bulens; Arthur Reingold; Susan Petit; Ken Gershman; Susan M Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; William Schaffner; Priti R Patel; Scott K Fridkin
Journal:  JAMA       Date:  2010-08-11       Impact factor: 56.272

4.  Pediatric Staphylococcus aureus Isolate Genotypes and Infections from the Dawn of the Community-Associated Methicillin-Resistant S. aureus Epidemic Era in Chicago, 1994 to 1997.

Authors:  Michael Z David; Mary Ellen Acree; Julia J Sieth; Dave J Boxrud; Ginette Dobbins; Ruth Lynfield; Susan Boyle-Vavra; Robert S Daum
Journal:  J Clin Microbiol       Date:  2015-05-27       Impact factor: 5.948

5.  The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus.

Authors:  Binh An Diep; Gregory G Stone; Li Basuino; Christopher J Graber; Alita Miller; Shelley-Ann des Etages; Alison Jones; Amy M Palazzolo-Ballance; Françoise Perdreau-Remington; George F Sensabaugh; Frank R DeLeo; Henry F Chambers
Journal:  J Infect Dis       Date:  2008-06-01       Impact factor: 5.226

6.  Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study.

Authors:  Pierre Charbonneau; Jean-Jacques Parienti; Pascal Thibon; Michel Ramakers; Cédric Daubin; Damien du Cheyron; Guy Lebouvier; Xavier Le Coutour; Roland Leclercq
Journal:  Clin Infect Dis       Date:  2006-02-07       Impact factor: 9.079

7.  A major reduction in hospital-onset Staphylococcus aureus bacteremia in Australia-12 years of progress: an observational study.

Authors:  Brett G Mitchell; Peter J Collignon; Rebecca McCann; Irene J Wilkinson; Anne Wells
Journal:  Clin Infect Dis       Date:  2014-06-27       Impact factor: 9.079

8.  Panton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studies.

Authors:  Amy Tong; Steven Y C Tong; Yurong Zhang; Supaporn Lamlertthon; Batu K Sharma-Kuinkel; Thomas Rude; Sun Hee Ahn; Felicia Ruffin; Lily Llorens; Ganesh Tamarana; Donald Biek; Ian Critchley; Vance G Fowler
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

9.  Community-acquired methicillin-resistant Staphylococcus aureus among military recruits.

Authors:  Craig E Zinderman; Byron Conner; Mark A Malakooti; James E LaMar; Adam Armstrong; Bruce K Bohnker
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

10.  MRSA in Africa: filling the global map of antimicrobial resistance.

Authors:  Matthew E Falagas; Drosos E Karageorgopoulos; John Leptidis; Ioanna P Korbila
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more
  40 in total

1.  Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016.

Authors:  Helio S Sader; Rodrigo E Mendes; Jennifer M Streit; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  Trends in Incidence of Methicillin-resistant Staphylococcus aureus Bloodstream Infections Differ by Strain Type and Healthcare Exposure, United States, 2005-2013.

Authors:  Isaac See; Yi Mu; Valerie Albrecht; Maria Karlsson; Ghinwa Dumyati; Dwight J Hardy; Mackenzie Koeck; Ruth Lynfield; Joelle Nadle; Susan M Ray; William Schaffner; Alexander J Kallen
Journal:  Clin Infect Dis       Date:  2020-01-01       Impact factor: 9.079

3.  The good side of inflammation: Staphylococcus aureus proteins SpA and Sbi contribute to proper abscess formation and wound healing during skin and soft tissue infections.

Authors:  Cintia D Gonzalez; Camila Ledo; Eliana Cela; Inés Stella; Chunliang Xu; Diego S Ojeda; Paul S Frenette; Marisa I Gómez
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-07-09       Impact factor: 5.187

4.  Skin and Soft Tissue Infection in People Living With Human Immunodeficiency Virus in a Large, Urban, Public Healthcare System in Houston, Texas, 2009-2014.

Authors:  Vagish Hemmige; Cesar A Arias; Siavash Pasalar; Thomas P Giordano
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079

Review 5.  Trends in Community Versus Health Care-Acquired Methicillin-Resistant Staphylococcus aureus Infections.

Authors:  David P Calfee
Journal:  Curr Infect Dis Rep       Date:  2017-11-03       Impact factor: 3.725

6.  Demographic fluctuation of community-acquired antibiotic-resistant Staphylococcus aureus lineages: potential role of flimsy antibiotic exposure.

Authors:  Claude-Alexandre Gustave; Anne Tristan; Patricia Martins-Simões; Marc Stegger; Yvonne Benito; Paal Skytt Andersen; Michèle Bes; Typhanie Le Hir; Binh An Diep; Anne-Catrin Uhlemann; Philippe Glaser; Frédéric Laurent; Thierry Wirth; François Vandenesch
Journal:  ISME J       Date:  2018-03-29       Impact factor: 10.302

7.  Modeling the Growth and Decline of Pathogen Effective Population Size Provides Insight into Epidemic Dynamics and Drivers of Antimicrobial Resistance.

Authors:  Erik M Volz; Xavier Didelot
Journal:  Syst Biol       Date:  2018-07-01       Impact factor: 15.683

8.  Exploration of the Structural Space in 4(3H)-Quinazolinone Antibacterials.

Authors:  Yuanyuan Qian; Giuseppe Allegretta; Jeshina Janardhanan; Zhihong Peng; Kiran V Mahasenan; Elena Lastochkin; Melissa Malia N Gozun; Sara Tejera; Valerie A Schroeder; William R Wolter; Rhona Feltzer; Shahriar Mobashery; Mayland Chang
Journal:  J Med Chem       Date:  2020-05-08       Impact factor: 7.446

9.  Back into the wild: how resistant pathogens become susceptible again?

Authors:  Solen Kernéis; Sandrine Valade; Paul-Louis Woerther
Journal:  Intensive Care Med       Date:  2020-02-03       Impact factor: 17.440

10.  Synthesis, Characterization, and Antimicrobial Investigation of a Novel Chlorhexidine Cyclamate Complex.

Authors:  Viktor Dubovoy; Primit Desai; Zhigang Hao; Chi-Yuan Cheng; Gaurav Verma; Lukasz Wojtas; Tatiana V Brinzari; Jeffrey M Boyd; Shengqian Ma; Tewodros Asefa; Long Pan
Journal:  Cryst Growth Des       Date:  2020-05-04       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.